Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-16 Gift | 2023-03-20 5:37 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 67,444 | $0 | 10,804,074 (Direct) | View |
| 2023-03-08 Exercise | 2023-03-10 6:48 pm | N/A 2023-04-03 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 879,255 | $0 | 10,871,530 (Direct) | View |
| 2023-03-08 Exercise | 2023-03-10 6:48 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 67,635 | $0.13 | 10,871,530 (Direct) | View |
| 2022-11-28 Gift | 2022-11-30 5:00 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 52,000 | $0 | 11,040,687 (Direct) | View |
| 2022-09-06 Gift | 2022-09-08 4:57 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 33,410 | $0 | 11,118,518 (Direct) | View |
| 2022-08-22 Other | 2022-08-24 4:15 pm | N/A N/A | BeiGene Ltd. | BGNE | Yi Qingqing Director | 7,800 | $0 | 24,492 (Direct) | View |
| 2022-08-22 Other | 2022-08-24 4:15 pm | N/A N/A | BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 7,800 | $0 | 147,050,858 (Indirect) | View |
| 2022-06-22 Option Award | 2022-06-24 5:40 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 2,221,687 | $0 | 51,773,418 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:40 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 833,131 | $0 | 2,276,053 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:40 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer | 694,265 | $0 | 835,471 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:39 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 1,249,690 | $0 | 2,066,046 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:39 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Dugan Margaret Director | 51,337 | $0 | 51,337 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:39 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 555,412 | $0 | 11,832,621 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:38 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director | 51,337 | $0 | 59,137 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:38 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Glazer Donald W. Director | 51,337 | $0 | 2,805,866 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:38 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 51,337 | $0 | 51,337 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:37 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director | 51,337 | $0 | 59,137 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:37 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Malley Thomas Director | 51,337 | $0 | 98,419 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:46 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 102,674 | $0 | 11,826,598 (Indirect) | View |
| 2022-06-22 Option Award | 2022-06-24 4:15 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Yi Qingqing Director | 51,337 | $0 | 59,137 (Direct) | View |
| 2022-05-17 Exercise | 2022-05-19 4:39 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 233,948 | $2.29 | 1,466,686 (Direct) | View |
| 2022-05-17 Exercise | 2022-05-19 4:39 pm | N/A 2026-07-13 | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 1,233,947 | $0 | 1,466,686 (Direct) | View |
| 2022-05-17 Exercise | 2022-05-19 4:39 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 999,999 | $3.49 | 1,466,686 (Direct) | View |